Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharmacia Preparing Defense Against Rochester COX-2 Patent Challenge

Executive Summary

Pharmacia is preparing to defend itself against a COX-2 inhibitor patent infringement suit brought by the University of Rochester rather than agreeing to pay royalties to the university.

You may also be interested in...

Pfizer prevails in COX-2 patent case

A University of Rochester patent claiming the use of COX-2 inhibitors to treat inflammation is invalid because it failed to identify the compounds claimed, a federal appeals court says in a 1ruling for Pfizer. The university sued Pfizer in 2000, alleging that the sale of the COX-2 inhibitors Celebrex (celecoxib) and Bextra (valdecoxib) infringed the patent (2"The Pink Sheet" April 17, 2000, p. 14)...

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts